
Study Physician - Medical Director, Neuroimmunology, Immunology, Biopharmaceuticals R&D
AstraZeneca
Summary
Are you a neurologist ready to lead a first-of-its-kind CAR-T cell therapy study that could redefine care for people living with multiple sclerosis? In this Study Physician role, you will serve as the study-level medical authority for a global, multi-cohort program in relapsing and progressive MS, directly shaping how novel immune therapies are delivered and assessed. Based at our state-of-the-art Kendall Square site in Cambridge, MA, you will work at the center of a world-leading life sciences ecosystem with direct access to collaborators, technology and patients.
Job description
Introduction to role
Are you a neurologist ready to lead a first-of-its-kind CAR-T cell therapy study that could redefine care for people living with multiple sclerosis? In this Study Physician role, you will serve as the study-level medical authority for a global, multi-cohort program in relapsing and progressive MS, directly shaping how novel immune therapies are delivered and assessed. Based at our state-of-the-art Kendall Square site in Cambridge, MA, you will work at the center of a world-leading life sciences ecosystem with direct access to collaborators, technology and patients.
You will partner closely with clinical scientists and cross-functional experts to keep patient safety at the forefront while driving decisive, data-led progress. Do you want to influence dose-escalation decisions, guide benefit-risk assessments and engage top MS investigators to accelerate a therapy that could change the trajectory of disease?
Accountabilities
- Medical Leadership and Study Design: Own the medical design, delivery and interpretation of a multi-cohort CAR-T study in MS, ensuring integrity, compliance with GCP and fast, well-reasoned decisions that move the program forward.
- Medical Monitoring Across the Patient Journey: Serve as medical monitor from eligibility review through apheresis, infusion and long-term follow-up, ensuring patient safety and clinical consistency across global sites.
- Safety Assessment and Governance: Lead assessment of adverse events, including CRS, ICANS, cytopenias and infections; guide dose-escalation, dose-hold and stopping-rule decisions within delegated authority; and represent the study at safety committees and internal governance.
- Data Synthesis and Decision-Making: Continuously review safety, efficacy, biomarkers and data-quality trends to detect signals early, shape study adaptations and ensure robust, decision-ready data.
- Clinical Adjudication: Adjudicate complex MS events, including relapse and disability progression, to secure consistent, high-quality endpoints.
- Scientific Documents and Results: Provide final medical review of protocols, amendments, ICFs, IB, SAPs and CSRs; lead medical interpretation of results; and contribute to clear, compelling regulatory documentation.
- External Engagement and Influence: Build strong relationships with investigators and MS experts; support investigator meetings; and contribute to regulatory interactions to align stakeholders around study priorities.
- Cross-Functional Strategy: Bring MS expertise to clinical pharmacology, translational medicine, regulatory, biostatistics, safety and CMC partners to integrate science, operations and strategy.
- Matrix Leadership and Mentorship: Lead through influence, escalate risks transparently and mentor colleagues to raise the bar on medical quality and delivery.
- Portfolio Contribution: Provide medical input to additional neuroimmunology indications and studies as the pipeline evolves, ensuring learnings scale beyond a single program.
Essential Skills/Experience
- MD or equivalent (PhD a plus), with board certification in neurology and substantive clinical experience in multiple sclerosis.
- Clinical research experience, including hands-on involvement in the design or delivery of clinical studies.
- Sound knowledge of MS trial methodology and endpoints (EDSS, relapses, MRI), biostatistics principles, and FDA, EMA and ICH GCP requirements.
- Ability to influence across a matrix and communicate complex decisions clearly, with a track record of delivering results.
Desirable Skills/Experience
- Biotech or pharmaceutical clinical-development experience, including oversight of industry-sponsored studies (strongly preferred).
- Experience with CAR-T, other cell therapies or B-cell-depleting therapies in MS or other autoimmune diseases.
- Experience in early-phase or first-in-human studies, including dose escalation.
- Ability to travel nationally and internationally.
Requirements
- MD or equivalent (PhD a plus)
- Board certification in neurology
- Substantive clinical experience in multiple sclerosis
- Clinical research experience, including hands-on involvement in the design or delivery of clinical studies
- Sound knowledge of MS trial methodology and endpoints (EDSS, relapses, MRI)
- Knowledge of biostatistics principles
- Knowledge of FDA, EMA and ICH GCP requirements
- Ability to influence across a matrix and communicate complex decisions clearly
- Track record of delivering results
- Biotech or pharmaceutical clinical-development experience, including oversight of industry-sponsored studies (strongly preferred)
- Experience with CAR-T, other cell therapies or B-cell-depleting therapies in MS or other autoimmune diseases
- Experience in early-phase or first-in-human studies, including dose escalation
- Ability to travel nationally and internationally
Benefits
- 401(k) Retirement Programs
- Paid Time Off
- Vacation
- Holidays
- Leaves
- Health Coverage
- Dental Coverage
- Vision Coverage
- Short-Term Incentive Bonuses
- Equity-Based Awards
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.